Executive Director, US Medical Affairs - Immunology

Salary: bonus + LTI

We are working with our client, an innovative organisation in the pharmaceuticals sector, to appoint an Executive Director, US Medical Affairs. This is a high-impact, permanent leadership role based in Boston (hybrid), driving US medical strategy in Immunology and shaping enterprise-level decisions across cross-functional partners. You will provide strategic direction grounded in a deep understanding of the therapeutic landscape and disease states, while leading and influencing senior stakeholders across our client's team.

• Opportunity to lead US Immunology Medical Affairs at an enterprise level, influencing strategy and execution across multiple functions.
• High-visibility role with senior leadership exposure, enabling progression into broader US or global medical leadership positions.
• Scope to shape long-term medical strategy, evidence generation plans, and cross-functional initiatives, expanding your strategic and operational remit.
• Platform to mentor and develop medical affairs teams, building a strong leadership profile and succession path within the organisation.

• 15+ years of progressive experience in Medical Affairs, demonstrating increasing leadership scope and strategic responsibility.
• Background in Immunology medical affairs leadership, with a clear track record of impact on US medical strategy and execution.

• MD, PhD, or PharmD preferred, supporting robust scientific and clinical engagement at the highest level.

• Medical Affairs Leadership: Proven ability to set and guide US Medical Affairs strategy, ensuring alignment with overall business goals.
• Enterprise-Level,
  
  Cross-Functional Collaboration:
  
  Experience working closely with multiple functions to drive cohesive, organisation-wide initiatives.
• Strategic Thinking in Therapeutic Landscape: Deep understanding of Immunology disease states and the evolving therapeutic environment to inform evidence generation and medical planning.
• US Market Focus: Strong appreciation of the USA healthcare and regulatory environment to shape impactful US medical strategies.